IRIS
MIMMI, SELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.214
AS - Asia 1.302
EU - Europa 911
SA - Sud America 184
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 24
OC - Oceania 5
Totale 4.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.125
SG - Singapore 641
IT - Italia 485
CN - Cina 301
BR - Brasile 150
DE - Germania 127
IN - India 105
VN - Vietnam 100
CA - Canada 65
FI - Finlandia 62
SE - Svezia 59
GB - Regno Unito 51
BD - Bangladesh 39
HK - Hong Kong 36
FR - Francia 24
MX - Messico 15
KR - Corea 14
NL - Olanda 14
ES - Italia 13
PL - Polonia 12
ID - Indonesia 11
ZA - Sudafrica 11
AR - Argentina 10
RO - Romania 10
JP - Giappone 9
CZ - Repubblica Ceca 8
RU - Federazione Russa 8
UA - Ucraina 8
CO - Colombia 6
IQ - Iraq 6
AT - Austria 5
PK - Pakistan 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EC - Ecuador 4
GR - Grecia 4
NP - Nepal 4
PT - Portogallo 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BB - Barbados 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
JO - Giordania 1
LK - Sri Lanka 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PW - Palau 1
PY - Paraguay 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 4.643
Salva come PNG Salva come JPEG
Città #
San Jose 391
Dallas 319
Singapore 272
Ashburn 188
Chandler 164
Santa Clara 98
Munich 92
Catanzaro 84
Bengaluru 73
Hefei 73
Council Bluffs 68
Milan 67
Beijing 63
Lawrence 59
Princeton 59
Turku 48
Ho Chi Minh City 38
Hong Kong 33
Ottawa 31
Wilmington 31
London 29
Seattle 29
Boardman 28
Los Angeles 28
Rome 21
Chicago 19
Des Moines 19
Hanoi 16
São Paulo 16
Taranto 16
Montreal 15
Napoli 14
Brooklyn 13
Helsinki 13
Shanghai 13
New York 11
Augusta 9
Naples 9
Paris 9
Redmond 9
Aversa 8
Buffalo 8
Olomouc 8
Redwood City 8
Foggia 7
Seoul 7
Amsterdam 6
Guangzhou 6
Haiphong 6
Johannesburg 6
Marano 6
Modena 6
Norwalk 6
Phoenix 6
Stockholm 6
Warsaw 6
Atlanta 5
Chennai 5
Florence 5
Frankfurt am Main 5
Hanover 5
Mexico City 5
Palermo 5
Providence 5
Pune 5
Rio de Janeiro 5
San Francisco 5
Teresina 5
The Dalles 5
Toronto 5
Boston 4
Da Nang 4
Edmonton 4
Heidesheim 4
Huế 4
Lahore 4
Lamezia Terme 4
Latina 4
Madrid 4
Padova 4
Reggio Calabria 4
Shenzhen 4
Tokyo 4
Târgu Mureş 4
Washington 4
Xi'an 4
Can Tho 3
Caserta 3
Chieti 3
Columbus 3
Crosia 3
Derby 3
Dubai 3
Felgueiras 3
Ferrara 3
Houston 3
Huddinge 3
Istanbul 3
Las Vegas 3
Louisville 3
Totale 2.869
Salva come PNG Salva come JPEG
Nome #
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 151
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 149
A Candidate multi-targeting approach to block the CD98hc oncoprotein 113
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 103
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 96
A novel phage display based platform for exosome diversity characterization 95
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 92
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 90
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 88
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 87
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 84
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 84
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 82
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 82
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 81
PEPTIDI E LORO USI 80
Crucial role for IBtk in the survival and maintenance of mature B cells 80
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 78
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 76
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 75
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 75
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 75
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 71
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 71
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 71
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 68
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 68
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 66
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 64
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 63
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 63
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 62
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 62
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 61
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 61
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 60
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 60
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 60
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 60
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 60
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 59
Phage Display: An Overview in Context to Drug Discovery 58
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 58
PEPTIDE AND USES THEREO 58
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 57
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 57
Phage Display: An Overview in Context to Drug Discovery 57
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 57
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 55
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 54
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 52
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 52
Belantamab mafodotin in multiple myeloma 51
Insights into Thymus Development and Viral Thymic Infections 51
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 51
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 50
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 50
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 49
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 45
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 45
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 45
Peptide-guided targeting of GPR55 for anti-cancer therapy. 45
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 38
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 33
Isatuximab in multiple myeloma 31
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 30
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 30
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 29
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 29
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 28
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 27
Peptide-guided targeting of GPR55 for anti-cancer therapy 26
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 22
Neurofilament Light Chain from Neuronally Derived Extracellular Vesicles in Differentiating Parkinson's Disease from Essential Tremor with Resting Tremor 13
New frontiers in porcine atrioventricular node decellularization: preserving extracellular matrix architecture for biological scaffolds 8
null 6
Emerging biomarkers in liquid biopsy: the small extracellular vesicles 5
null 2
Totale 4.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022260 0 2 13 56 20 12 15 60 19 34 27 2
2022/2023552 120 26 37 23 50 37 7 53 107 38 41 13
2023/2024304 58 37 31 23 21 63 4 9 6 6 17 29
2024/20251.026 128 37 45 37 96 102 27 25 142 25 145 217
2025/20262.176 148 216 361 214 213 99 262 120 242 137 115 49
2026/2027101 15 86 0 0 0 0 0 0 0 0 0 0
Totale 4.748